Abstract

Mammalian hexokinases (HKs) I-III are composed of two highly homologous approximately 50-kDa halves. Studies of HKI indicate that the C-terminal half of the molecule is active and is sensitive to inhibition by glucose 6-phosphate (G6P), whereas the N-terminal half binds G6P but is devoid of catalytic activity. In contrast, both the N- and C-terminal halves of HKII (N-HKII and C-HKII, respectively) are catalytically active, and when expressed as discrete proteins both are inhibited by G6P. However, C-HKII has a significantly higher Ki for G6P (KiG6P) than N-HKII. We here address the question of whether the high KiG6P of the C-terminal half (C-half) of HKII is decreased by interaction with the N-terminal half (N-half) in the context of the intact enzyme. A chimeric protein consisting of the N-half of HKI and the C-half of HKII was prepared. Because the N-half of HKI is unable to phosphorylate glucose, the catalytic activity of this chimeric enzyme depends entirely on the C-HKII component. The KiG6P of this chimeric enzyme is similar to that of HKI and is significantly lower than that of C-HKII. When a conserved amino acid (Asp209) required for glucose binding is mutated in the N-half of this chimeric protein, a significantly higher KiG6P (similar to that of C-HKII) is observed. However, mutation of a second conserved amino acid (Ser155), also involved in catalysis but not required for glucose binding, does not increase the KiG6P of the chimeric enzyme. This resembles the behavior of HKII, in which a D209A mutation results in an increase in the KiG6P of the enzyme, whereas a S155A mutation does not. These results suggest an interaction in which glucose binding by the N-half causes the activity of the C-half to be regulated by significantly lower concentrations of G6P.

Highlights

  • The D209A mutation in HKII results in complete inactivation of the N-terminal half (N-half) of HKII [7], so the activity of the D209A enzyme is entirely contributed by its C-terminal half (C-half)

  • Neither the S155A mutation, which inactivates the N-half of the enzyme, nor the S603A mutation affect the Ki for G6P (KiG6P) of the intact enzyme (Table II)

  • These data suggest that S155A and D209A have different roles in HKII, with respect to the regulation of the catalytic activity of the C-half by glucose 6-phosphate (G6P)

Read more

Summary

EXPERIMENTAL PROCEDURES

Construction of NICII Chimeric Proteins—The human hexokinase I cDNA was provided by Dr Graeme Bell (Howard Hughes Medical Institute, University of Chicago). PGST1⁄7NHKI was digested with NcoI and BssHII (a cleavage site about 1.2 kbp 5Ј of the GST start codon) to produce a fragment of ϳ3.2 kbp that contains the coding sequence of GST and the N-terminal half of HKI. This fragment was purified by size separation through agarose gel electrophoresis and was isolated using Spin-x tubes (Costar, Cambridge, MA). To use the glucose tracer data directly in the determination of the kinetic parameters, we modified the hexokinase rate law by dividing both sides of the equation by the concentration of glucose to correct for the specific activity of the tracer. The kinetic parameters (i.e. KmGlc, KmATP, and KiG6P) were determined by analyzing the measured activities as a function of changes in each of the substrate and inhibitor concentrations

RESULTS AND DISCUSSION
Annealing temperature
Functional Organization of Mammalian Hexokinase II
Km ATP
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.